113081-49-5

Basic information

• Product Name: Benzene, 1-bromo-4-(chloromethyl)-2-methoxy-
• CAS NO: 113081-49-5
• Molecular Formula: C8H8BrClO
• Molecular Weight: 235.508
• Mol File: 113081-49-5.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Benzene, 1-bromo-4-(chloromethyl)-2-methoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1-bromo-4-(chloromethyl)-2-methoxy-(113081-49-5)
• EPA Substance Registry System: Benzene, 1-bromo-4-(chloromethyl)-2-methoxy-(113081-49-5)

Safety Data

• Hazardous Substances Data: 113081-49-5(Hazardous Substances Data)

Usage

General Description

Benzene, 1-bromo-4-(chloromethyl)-2-methoxy- is a chemical compound with the molecular formula C8H8BrClO. It is a derivative of benzene, with a bromine atom attached to the first carbon, a chloromethyl group attached to the fourth carbon, and a methoxy group attached to the second carbon. Benzene, 1-bromo-4-(chloromethyl)-2-methoxy- is commonly used in organic synthesis and pharmaceutical research. It is important to handle this chemical with caution as it is potentially hazardous, with risks of irritation to the skin, eyes, and respiratory system, and may have toxic effects if swallowed or inhaled. Additionally, it can be harmful to aquatic life and may persist in the environment. Therefore, proper safety measures and handling procedures should be followed when working with this compound.

Upstream product

• 17100-63-9 methyl 4-bromo-3-methoxybenzoate 
• 17100-64-0 (4-bromo-3-methoxyphenyl)methanol 
• 124-63-0 methanesulfonyl chloride 

Downstream Products

• 113081-50-8 2-(4-bromo-3-methoxyphenyl)acetonitrile 
• 1403330-17-5 2-[(4-bromo-3-methoxybenzyl)(ethyl)amino]-2-methylpropan-1-ol 
• 1147886-81-4 1-bromo-4-((R)-2-ethoxy-propoxymethyl)-2-methoxy-benzene 

Relevant articles and documents

COMPOUNDS AND THEIR METHODS OF USE

The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persis

SUBSTITUTED FUSED BI- OR TRI- HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS

The present disclosure relates to substituted fused bi- or tri- heterocyclic compounds. The present disclosure also relates to pharmaceutical compositions containing these compounds and methods of treating a disorder (e.g., sickle cell anemia) via inhibit

TRIAZOLOPYRIDINES

The present invention relates to triazolopyridine compounds of general formula (I) : in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said com